Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 07-oct-2026 · last seen 07-oct-2026

Myostatin Inhibitors

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-10-03 — Myostatin inhibitors and the paradox of larger but weaker muscles: Peter Attia (podcast/media commentary) frames the class-wide paradox: both older and newer myostatin-pathway inhibitors can preserve or increase lean mass without reliably improving muscle strength — expert synthesis of existing trial readouts, not a new study. [expert-opinion] (novelty: 3)

Open questions

Related

Contributing findings

rss expert media expert-opinion
Myostatin inhibitors and the paradox of larger but weaker muscles
03-oct-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18